Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $362.14 | $19.67 | 1,741.09% | 7,242.80x | 106.90x | 8.02x | 9.71x | 6.99x | $529.27M | 1.33% | $4.13B | 37.48 | $37.98B | 119.43 | ||
| NVO | NOVO NORDISK A S | $47.42 | $152.21 | -68.84% | 13.00x | 2.08x | 4.33x | 6.90x | 0.14x | $9.33B | 4.41% | $30.70B | 6.88 | $228.26B | 9.46 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $47.77 | $18.07 | 164.42% | 97.49x | 29.95x | 5.97x | 6.76x | 1.18x | $101.73M | 2.85% | $535.38M | 7.17 | $3.46B | 64.50 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.80 | $16.77 | -47.52% | 18.33x | 15.54x | 5.84x | 3.72x | 0.24x | -$23.64M | -4.81% | $133.17M | 2.38 | $503.70M | 7.49 | ||
| CORT | CORCEPT THERAPEUTICS INC | $34.82 | $42.51 | -18.09% | 34.82x | 56.27x | 4.86x | 5.80x | 0.36x | $162.57M | 4.51% | $631.90M | 6.10 | $3.54B | 53.71 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $336.19 | $109.07 | 208.22% | 140.67x | 50.19x | 11.86x | 56.50x | 1.32x | $465.38M | 1.06% | $789.18M | 6.02 | $45.90B | 72.69 | ||
| VCEL | VERICEL CORP | $38.09 | $9.76 | 290.29% | 146.50x | 67.20x | 7.43x | 5.99x | 1.73x | $20.38M | 1.06% | $321.86M | 6.38 | $1.92B | 65.64 | ||
| ARGX | ARGENX SE | $844.41 | $377.69 | 123.57% | 33.74x | 28.17x | 27,239.03x | 7.19x | 1.37x | $467.72M | 0.91% | $7.17B | 117.50 | $49.13B | 60.56 | ||
| GMAB | GENMAB A | $29.29 | $106.28 | -72.44% | 18.90x | 1.73x | 5.06x | 3.22x | 0.11x | $1.13B | 6.01% | $5.85B | 9.10 | $22.53B | 14.59 | ||
| KRYS | KRYSTAL BIOTECH INC | $261.80 | $121.60 | 115.29% | 36.98x | 31.43x | 19.47x | 6.28x | 1.22x | $189.35M | 2.50% | $1.22B | 42.14 | $7.17B | 36.56 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $183.98 | $73.77 | 149.40% | 79.65x | 21.75x | 14.34x | 3.81x | 1.14x | $30.76M | 0.85% | $950.17M | 48.53 | $3.93B | 38.18 | ||
| TECH | BIO-TECHNE CORP | $57.52 | $16.78 | 242.72% | 110.62x | 28.48x | 7.37x | 4.48x | 1.57x | $223.02M | 2.49% | $2.01B | 12.90 | $9.18B | 40.53 | ||
| ADMA | ADMA BIOLOGICS INC | $16.10 | $13.00 | 23.86% | 18.30x | 17.64x | 7.86x | 8.89x | 0.77x | $40.73M | 1.06% | $431.19M | 1.81 | $3.84B | 22.33 | ||
| MNKD | MANNKIND CORP | $5.54 | $2.99 | 85.18% | 55.40x | 63.46x | 5.42x | -38.18x | 0.86x | $43.39M | 2.55% | -$44.55M | -0.15 | $1.93B | 26.42 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.26 | $19.50 | -73.03% | 3.31x | -97.59x | 751.43x | 1.66x | 0.19x | -$82.36M | -28.86% | $171.23M | 3.16 | $225.93M | 2.51 | ||
| HALO | HALOZYME THERAPEUTICS INC | $70.98 | $73.95 | -4.02% | 26.89x | 8.52x | 6.09x | 171.61x | 0.45x | $644.59M | 7.58% | $48.81M | 0.41 | $10.38B | 18.12 | ||
| RPRX | ROYALTY PHARMA PLC | $45.12 | $48.11 | -6.22% | 25.21x | 8.70x | 8.15x | 2.68x | 0.45x | $2.22B | 11.44% | $9.71B | 22.60 | $34.36B | 31.86 | ||
| VCYT | VERACYTE INC | $35.63 | $12.69 | 180.74% | 91.36x | 31.53x | 5.67x | 2.24x | 1.28x | $98.21M | 3.50% | $1.26B | 15.98 | $2.54B | 44.56 | ||
| XOMA | XOMA ROYALTY CORP | $25.81 | $16.17 | 59.59% | 31.86x | 82.09x | 6.65x | 3.63x | 0.85x | -$12.41M | -3.96% | $87.94M | 7.25 | $361.04M | 13.50 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.86 | $4.41 | 10.15% | 18.00x | 16.15x | 3.11x | 5.49x | 0.64x | $21.15M | 5.45% | $70.68M | 0.89 | $326.62M | 14.39 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $3.06 | $3.65 | -16.10% | 43.71x | 17.31x | 3.92x | 4.65x | 0.35x | -$11.69M | -4.80% | $52.91M | 0.67 | $240.62M | 27.12 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.16 | $64.64 | -54.89% | 9.03x | 6.75x | 2.03x | 2.01x | 0.24x | $296.89M | 17.69% | $835.12M | 14.51 | $1.20B | 4.45 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.30 | $23.98 | 1.32% | 13.58x | 13.38x | 5.15x | 3.25x | 0.67x | $234.54M | 7.87% | $920.25M | 7.51 | $2.30B | 7.10 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.40 | $10.05 | 43.29% | 24.83x | 15.10x | 7.14x | 5.19x | 0.81x | $119.87M | 6.31% | $365.77M | 2.78 | $1.90B | 18.39 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $22.28 | $6.28 | 254.85% | 63.66x | -19.39x | 2.77x | 7.03x | 1.97x | $78.64M | 2.79% | $401.17M | 3.17 | $2.81B | 30.13 | ||
| CRMD | CORMEDIX INC | $7.03 | $14.84 | -52.61% | 3.10x | 4.32x | 2.49x | 1.48x | 1.73x | $74.42M | 13.94% | $374.13M | 4.93 | $654.31M | 5.83 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $779.67 | $455.39 | 71.21% | 18.10x | 16.78x | 5.69x | 2.64x | 1.44x | $4.08B | 5.00% | $31.26B | 298.82 | $82.01B | 14.10 | ||
| UTHR | UNITED THERAPEUTICS CORP | $473.42 | $260.37 | 81.83% | 16.62x | 16.06x | 6.63x | 3.09x | 1.90x | $1.12B | 5.41% | $6.59B | 150.46 | $19.04B | 10.74 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $64.08 | $52.36 | 22.38% | 23.56x | 14.45x | 3.98x | 2.03x | 0.66x | $832.13M | 6.76% | $6.06B | 31.54 | $11.66B | 15.09 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $23.99 | $12.43 | 92.99% | 15.28x | 31.36x | 3.87x | 4.42x | 2.79x | $197.81M | 4.89% | $917.27M | 5.43 | $3.83B | 13.33 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $476.90 | $192.47 | 147.78% | 30.85x | 23.39x | 10.16x | 6.49x | 1.75x | $3.19B | 2.62% | $18.67B | 73.00 | $117.91B | 24.23 | ||
| INVA | INNOVIVA INC | $23.39 | $19.80 | 18.15% | 12.38x | 10.70x | 4.16x | 1.73x | 1.00x | $196.54M | 12.17% | $1.01B | 14.63 | $1.53B | 7.12 | ||
| EXEL | EXELIXIS INC | $43.63 | $36.58 | 19.29% | 15.15x | 13.43x | 5.11x | 5.24x | 0.83x | $875.84M | 7.39% | $2.16B | 7.96 | $11.02B | 11.08 | ||
| MDXG | MIMEDX GROUP INC | $5.17 | $2.74 | 88.78% | 18.46x | 46.08x | 1.95x | 3.20x | 1.76x | $66.82M | 8.72% | $238.95M | 1.61 | $641.82M | 9.27 | ||
| INCY | INCYTE CORP | $101.32 | $76.76 | 31.99% | 15.37x | 12.65x | 3.85x | 3.90x | 0.99x | $1.35B | 6.85% | $5.17B | 26.47 | $17.10B | 9.71 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.